These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 25590290

  • 1. Homocysteine-lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ, Solà I, Lathyris D.
    Cochrane Database Syst Rev; 2015 Jan 15; 1():CD006612. PubMed ID: 25590290
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prophylactic lidocaine for myocardial infarction.
    Martí-Carvajal AJ, Simancas-Racines D, Anand V, Bangdiwala S.
    Cochrane Database Syst Rev; 2015 Aug 21; 2015(8):CD008553. PubMed ID: 26295202
    [Abstract] [Full Text] [Related]

  • 7. Interventions for lowering plasma homocysteine levels in kidney transplant recipients.
    Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiya T, Strippoli GF, Jardine MJ.
    Cochrane Database Syst Rev; 2015 May 04; 2015(5):CD007910. PubMed ID: 25938479
    [Abstract] [Full Text] [Related]

  • 8. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H, Kammler J, Domanovits H, Schlager O, Wildner B, Azar D, Schillinger M, Wiesbauer F, Steinwender C.
    Cochrane Database Syst Rev; 2014 Sep 18; (9):CD004476. PubMed ID: 25233038
    [Abstract] [Full Text] [Related]

  • 9. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T.
    Cochrane Database Syst Rev; 2013 Apr 30; (4):CD009008. PubMed ID: 23633364
    [Abstract] [Full Text] [Related]

  • 10. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.
    Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154
    [Abstract] [Full Text] [Related]

  • 11. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E, Lip GY.
    Cochrane Database Syst Rev; 2016 Sep 15; 9(9):CD003333. PubMed ID: 27629776
    [Abstract] [Full Text] [Related]

  • 12. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL, Algra A, van Gijn J.
    Cochrane Database Syst Rev; 2003 Sep 15; (1):CD001820. PubMed ID: 12535415
    [Abstract] [Full Text] [Related]

  • 13. Colchicine for prevention of cardiovascular events.
    Hemkens LG, Ewald H, Gloy VL, Arpagaus A, Olu KK, Nidorf M, Glinz D, Nordmann AJ, Briel M.
    Cochrane Database Syst Rev; 2016 Jan 27; 2016(1):CD011047. PubMed ID: 26816301
    [Abstract] [Full Text] [Related]

  • 14. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
    Andras A, Stansby G, Hansrani M.
    Cochrane Database Syst Rev; 2013 Jul 19; 2013(7):CD003285. PubMed ID: 23881650
    [Abstract] [Full Text] [Related]

  • 15. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.
    Mao C, Fu XH, Yuan JQ, Yang ZY, Chung VC, Qin Y, Huang Y, Tam WW, Kwong JS, Xie W, Tang JL.
    Cochrane Database Syst Rev; 2015 May 21; 2015(5):CD010237. PubMed ID: 25994229
    [Abstract] [Full Text] [Related]

  • 16. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis.
    Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V.
    BMJ; 2012 Jun 13; 344():e3533. PubMed ID: 22695899
    [Abstract] [Full Text] [Related]

  • 17. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
    Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Sleight P, Peto R, Collins R.
    JAMA; 2010 Jun 23; 303(24):2486-94. PubMed ID: 20571015
    [Abstract] [Full Text] [Related]

  • 18. Non-pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack.
    Mackay-Lyons M, Thornton M, Ruggles T, Che M.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD008656. PubMed ID: 23543566
    [Abstract] [Full Text] [Related]

  • 19. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial.
    Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, Pfeffer MA, Selhub J, Jacques PF, Cole E, Gravens-Mueller L, House AA, Kew C, McKenney JL, Pacheco-Silva A, Pesavento T, Pirsch J, Smith S, Solomon S, Weir M.
    Circulation; 2011 Apr 26; 123(16):1763-70. PubMed ID: 21482964
    [Abstract] [Full Text] [Related]

  • 20. Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map.
    Khan SU, Khan MU, Riaz H, Valavoor S, Zhao D, Vaughan L, Okunrintemi V, Riaz IB, Khan MS, Kaluski E, Murad MH, Blaha MJ, Guallar E, Michos ED.
    Ann Intern Med; 2019 Aug 06; 171(3):190-198. PubMed ID: 31284304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.